Recall Alert: Popular Candy Pulled From Shelves At Major Retail Chains
Aside from their high price tag and fat content, there may be another reason to think twice before eating macadamia nuts. Mauna Loa Macadamia Nut Company, a popular Hawaii-based candy manufacturer, has just voluntarily recalled some of its products sold at ACME Markets, Walmart, and Target. Mauna Loa Dark Chocolate Covered Macadamias were recalled due to the possible presence of undeclared almonds and cashews. This issue could be life-threatening for anyone with severe allergies. Luckily, no allergic reactions have been reported. The issue seems to have been caught in time, so Mauna Loa will avoid the list of the most deadly recalled foods in U.S. history such as the one that affected Boar's Head deli meat in 2024.
The chocolate-covered nuts are manufactured by a third party, and the mistake was found during an internal quality control process conducted by Mauna Loa. The candy company took immediate action to recall the product, alerting the FDA and consumers. This incident is far from the only recall involving chocolate; Some of the biggest chocolate recalls in history include Nestlé Toll House recalling its Chocolate Chip Cookie Dough in 2009 and 2023 as well as Betty Crocker recalling its Triple Chunk Brownie Mix in 2003.
Read more: False Things You Believe About Shopping At Aldi
The affected bags of the Mauna Loa Dark Chocolate Covered Macadamias were distributed across multiple retail locations in multiple states and regions, including Arizona, California, Colorado, Florida, Hawaii, Illinois, Maine, Michigan, New Jersey, Oregon, Pennsylvania, Texas, Utah, Virgina, Washington, Wisconsin, and Guam. The recall affects 0.6 and 4-ounce bags.
The affected 0.6-bags have a Universal Product Code (UPC) of 0 72992 05464 4 and is marked with one of two lot numbers: K5069C1 or K5069C2. Additionally, the best buy date is 10/2026. Affected 4-ounce bags have the UPC code 0 72992 05556 6 and either B4339E1 or B4340E1 as lot numbers. The best buy date is 07/2026. Be sure to check if you have these products as soon as possible — especially if you or a family member have an allergy to almonds or cashews. You can return the affected bags for a full refund. If you have any questions, contact Mauna Loa Macadamia Nut Company's customer service at 1-888-255-5998.
Read the original article on Mashed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Boston Globe
an hour ago
- Boston Globe
Will Trump's policies kill Massachusetts' life sciences leadership?
Advertisement Although the industry is centered in eastern Massachusetts, there's a statewide benefit from all the tax dollars those businesses and workers pay. Get The Gavel A weekly SCOTUS explainer newsletter by columnist Kimberly Atkins Stohr. Enter Email Sign Up In all, Massachusetts organizations — including universities, research institutes, and hospitals — received $3.5 billion in funding from the National Institutes of Health. Massachusetts-headquartered companies raised $3.26 billion in venture capital funding. Among all drugs in the development pipeline in the United States, 15 percent were being made by companies headquartered in Massachusetts. But actions taken by President Trump and his administration — cutting funding for scientific research and universities, flirting with tariffs, fanning skepticism about vaccines — threaten to devastate the ecosystem. Today, the industry is at a precipice, and uncertainty abounds. Some companies are already feeling the pinch of terminated federal grants, while others are anxious about what might come. Taken together, Trump's policies could force some companies and scientists to take their money, talents, and products overseas. Advertisement Christopher Locher, CEO of Lowell-based Versatope Therapeutics, which develops a platform to deliver vaccines and therapeutics, said he worries the Greater Boston life sciences ecosystem is 'being flushed down the toilet.' For example, Trump is Trump's funding cuts are already having a large impact on some local companies. Part of the problem is the Trump administration isn't only cutting funding, but it's picking which technologies to fund — in some cases apparently based on politics more than science. Take flu vaccines. The Trump administration recently announced a $500 million campaign to fund the development of a universal flu vaccine, which doesn't require annual updates, using technology being worked on But simultaneously, he cut funding for other work on a universal flu vaccine. Versatope Therapeutics got $14 million in NIH funding and spent five years developing a universal flu vaccine. It had approval from the US Food and Drug Administration to begin clinical trials when Trump terminated the contract's remaining $8 million, with the reason given being 'convenience,' Locher said. Trump also Advertisement Company executives say decisions by Trump officials to disinvest in vaccine-related technology — and concerns about whether government will approve new technology — means it's nearly impossible to find private investment funding to replace lost federal dollars. 'We're faced with bankruptcy in the very near future,' Locher said. Ironically, given Trump's stated commitment to bringing businesses back to the United States, one potential option Locher is eyeing is opening a subsidiary abroad. Conducting clinical trials would be cheaper in another country, whether in Europe, Australia, or China, Locher said, and some countries are offering financial incentives to American companies to relocate. Companies also face a potential workforce brain drain. There have been MassBio officials said China has less rigorous — but faster — safety and research protocols than the US. Australia allows a faster timeline for clinical trials. If regulatory approval of medicines is held up because the FDA is understaffed, companies may seek European regulatory approval instead. The loss of talent to foreign countries will be compounded if the pipeline of local university graduates dries up. One draw for life sciences companies to Boston/Cambridge is the presence of elite schools like Harvard and MIT, with their potential for faculty collaboration and skilled graduates. Advertisement Trump is trying to Chip Clark, CEO at Vibrant Biomedicines in Cambridge, said cuts to university research funding both 'shrink the pipeline of great ideas' that form the basis for many biotech startups and translate to fewer available scientists. Clark said the administration's policies 'seem like a deliberate attempt to try to cede scientific leadership to Europe and Japan and Korea and China. ... They will be delighted to capitalize on our talent, technology, and investment capital to make their robust biotech sectors grow and ultimately compete successfully against the US industry,' he said. Don Ingber, founding director of the Wyss Institute for Biologically Inspired Engineering at Harvard University, said he has postdocs with US visas applying for jobs in Europe, and others who were accepted to work at Harvard but are going elsewhere. 'The fact that places like Harvard and MIT and American universities are magnets for the best and brightest from around the world is what's driven our technology economy and certainly the Boston/Cambridge ecosystem,' Ingber said. 'With this uncertainty, I fear we'll lose a generation.' Ingber, who was forced to stop work on two government-funded projects on drugs designed to prevent injury from radiation exposure, compared administration policies to 'eating seed corn' needed to grow crops. Advertisement Trump's vendetta will undermine one of the most vibrant state economies in the country and set back American science by years. And it's not just eastern Massachusetts that will pay a price; the entire country will. As Ingber noted, it might take years to see the impact of medicines or technologies that aren't developed because of these shortsighted cuts. Editorials represent the views of the Boston Globe Editorial Board. Follow us
Epoch Times
13 hours ago
- Epoch Times
Nasal, Baby Teething Swabs Recalled Nationwide Over Microbial Contamination Fears
New Jersey-based Church & Dwight Co., Inc. is recalling three nasal and baby teething swab products due to potential fungal contamination in the cotton swab components, the company said in a June 6 The recall is applicable to three products: Zicam Cold Remedy Nasal Swabs designed to tackle the common cold, Zicam Nasal AllClear Swabs used for cleansing, and Orajel Baby Teething Swabs aimed at soothing teething discomfort among toddlers and infants.
Business Upturn
13 hours ago
- Business Upturn
HepatoBurn Announces Official Website Update Featuring Natural Daily Supplement for Metabolic Health and Liver Function
Taylor, June 07, 2025 (GLOBE NEWSWIRE) — HepatoBurn, a U.S.-based wellness brand, has updated its official website to share new information about its natural daily supplement formulated to support metabolic health and liver function in adults. Now available nationwide, the plant-based formula is positioned as a convenient, routine-friendly option for individuals seeking natural metabolic balance and detox support. According to the official product website ( HepatoBurn is designed to work synergistically with the body's internal systems to help maintain a healthy metabolism and support the liver's natural detoxification processes. The company emphasizes ease of use, noting that the supplement fits into everyday routines without the need for restrictive diets or complex wellness regimens. 'We created HepatoBurn to help individuals feel more energized, supported, and balanced,' said a company spokesperson. 'Our goal is to simplify wellness through science-backed, natural ingredients that integrate into daily life.' The company confirms that HepatoBurn is manufactured in U.S.-based facilities following rigorous safety and quality control standards. While the formula's specific ingredients are detailed on the official website, the product is crafted for adults seeking support with healthy energy levels, metabolic efficiency, and overall wellness. As stated on the site, first-time customers are backed by a satisfaction guarantee. Those interested in learning more about HepatoBurn, its intended benefits, and how to purchase directly can access full product details, FAQs, and secure ordering options through the official website. About HepatoBurn HepatoBurn is a Michigan-based wellness brand committed to delivering natural health supplements that are easy to use, transparent in formulation, and built for daily lifestyle integration. The company's mission is to help adults pursue optimal wellness through trustworthy, quality-driven solutions. Product and Contact Information Brand: HepatoBurn Website: Email: [email protected] Phone: +1 855-391-2736 Mailing Address: 22701 Trolley Industrial Dr Suite C, Taylor, MI 48180, USA Disclaimer This release is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. The statements made about this product have not been evaluated by the Food and Drug Administration. Individual results may vary. Consumers should consult a qualified healthcare provider before beginning any new dietary supplement. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
